It introduced pre-filled disposable insulin syringes, updated the NovoPen, launched an antidepressant, new hemophilia treatments, diabetes pills, and much more
37 GreenmanYTordjmanKSternN
Marcel Arnold: Honoraria for lecturs: Astra Zeneca, Bayer, Novartis, Sanofi, Scientific advisory boards: Amgen, BMS/Pfizer, Novo Nordisk, Daiichi Sankyo, Medtronic, Novartis, Grants Swiss National Science Foundation Poster session I - DIAGNOSIS / ETIOLOGY 04.00 - DIAGNOSIS / ETIOLOGY - 04.10 - ESUS/CRYPTOGENIC STROKE P326 - ESOC25-2305 A MACHINE LEARNING BASED APPROACH TO IDENTIFY ESUS ETIOLOGIES Adriano Bonura 1 , Claudia Meza 1 , Jesus Juega 1 , Marian Muchada 1 , Alvaro Garcia-Tornel 1 , Federica Rizzo 1 , Renato Simonetti 1 , Marta Olive 1 , Marc Rodrigo 1 , Noelia Rodriguez-Villatoro 1 , David Rodriguez Luna 1 , Marta Rubiera 1 , Carlos Molina 1 , Jorge Pagola 1 Vall dHebron, Stroke Unit, Barcelona, Spain Background and Aims: Embolic Stroke of Undetermined Source (ESUS) accounts for about one-quarter of all ischemic strokes and poses a notable challenge in modern vascular neurology due to its high recurrence rate and diverse underlying mechanisms
While glutathione is generally considered safe when used appropriately, some individuals may experience side effects such as allergic reactions at injection sites or gastrointestinal discomfort when taken orally
Ninguno de los pacientes consuma otros frmacos que pudieran estar implicados en el desarrollo de los efectos cutneos observados
